HZO Form 144 outlines planned 10,000-share NYSE sale via Raymond James

Rhea-AI Filing Summary

HZO has a Form 144 notice showing a planned sale of 10,000 shares of its common stock. The shares are to be sold through Raymond James & Associates on the NYSE, with an aggregate market value of $219,676.05 and 21,870,000 shares outstanding. The proposed sale date is approximately 11/21/2025.

The 10,000 shares come from restricted stock units granted by the issuer and acquired on several dates between 03/31/2021 and 09/30/2025, all listed as cash-settled awards. The person filing represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	10000	219676.05	21870000	11/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/31/2021	RSU	Issuer			945	03/31/2021	Cash
Common	03/21/2023	RSU	Issuer			839	03/21/2023	Cash
Common	03/31/2025	RSU	Issuer			743	03/31/2025	Cash
Common	09/30/2025	RSU	Issuer			7473	09/30/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does HZO's Form 144 filing disclose?

The Form 144 discloses a planned sale of 10,000 shares of HZO common stock under Rule 144, to be executed through Raymond James & Associates on the NYSE.

How many HZO shares are planned to be sold and what is their value?

The filing lists 10,000 common shares with an aggregate market value of $219,676.05.

When is the planned sale date for the HZO shares under Form 144?

The approximate sale date disclosed is 11/21/2025.

How many HZO shares are outstanding according to this Form 144?

The notice states that 21,870,000 shares of HZO common stock are outstanding.

How were the HZO shares in this Form 144 acquired?

The 10,000 shares were acquired as restricted stock units (RSUs) from the issuer on dates including 03/31/2021, 03/21/2023, 03/31/2025, and 09/30/2025, with cash listed as the nature of payment.

What representation does the seller make in HZO's Form 144?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.